Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
The FDA enforcement-discretion period that allowed mass compounding during the tirzepatide shortage ended on March 19, 2025 for 503B outsourcing facilities and February 18, 2025 for 503A pharmacies
You have no way of knowing if the product is pure, contains the correct dose, or is contaminated
PMID 25195560
TB-500: the Thymosin Beta-4 analogue TB-500 is a synthetic analogue or fragment of Thymosin Beta-4, a 43-amino-acid actin-sequestering protein involved in cell migration, angiogenesis, and wound healing [5]
Dial 911 (or a local emergency number)
How is my data protected
US$ 28.10
US$ 23.79
US$ 25.78
US$ 24.35
US$ 27.09
US$ 20.81
US$ 29.96
US$ 22.20
